![](/documents/176177/179111/news-generic.jpg)
Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
19 Jul 2024
Catalonia's nautical sector generates over €1 billion and creates 4,000 jobs
-
17 Jul 2024
Discover Catalonia’s 10 most disruptive companies of 2024
-
11 Jul 2024
Catalonia leads a €23 million European project for personalized medicine and advanced therapies
-
10 Jul 2024
Port of Barcelona launches a pioneering 5G network in Europe